IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q2 2014 Holdings

Filed 2014-08-13 | 17 holdings | $22.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$22.2M1,744,35699.3%
GW PharmaceuticalsCOM36197T103$33.5K311,8530.1%
Anacor Pharmaceuticals IncCOM032420101$27.4K1,545,9990.1%
Dyax CorpCOM26746E103$19.2K2,000,8590.1%
Heron Therapeutics Inc(HRTX)COM427746102$13.5K1,095,7340.1%
DBV TechnologiesCOMF2927N109$12.5K480,0000.1%
Keryx Biopharmaceuticals IncCOM492515101$10.8K700,2730.0%
Zafgen IncCOM98885E103$10.7K541,4800.0%
Flamel Technologies S.A.COM338488109$7.5K500,0000.0%
Radius Health IncCOM750469108$6.8K525,0000.0%
Ocera TherapeuticsCOM67552A108$5.4K703,7300.0%
OHR PharmaceuticalCOM67778H200$4.5K477,0000.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$4.5K303,5030.0%
TherapeuticsMD IncCOM88338N107$3.7K846,5000.0%
ZS Pharma IncCOM98979G105$2.9K100,0000.0%
Alexza Pharmaceuticals IncCOM015384100$1.1K247,8120.0%
Lipocine IncCOM53630X104$867142,1000.0%